Tom Wei‐Wu Chen

机构：National Taiwan University, National Taiwan University Hospital · ORCID：0000-0003-4112-4029

发表论文 161 篇 · 总被引 5422 次 · h-index 26

代表论文

• Angiosarcoma: Role of Immunotherapy (2025 · Current Treatment Options in Oncology · 被引 8)
• Tazemetostat, an EZH2 inhibitor, in solid tumors harboring SWI/SNF alterations: a phase II basket study (2026 · Nature Communications · 被引 3)
• Carcinomas exhibiting epithelial–mesenchymal transition manifest an M2 macrophage-enriched tumor immune microenvironment (2025 · Breast Cancer Research · 被引 3)
• A Phase 3 Study of the Efficacy and Safety of Pexidartinib in East Asian Patients with Tenosynovial Giant Cell Tumor (2025 · Oncology and Therapy · 被引 3)
• Maintenance therapy—a potential strategy to prolong the survival of advanced soft tissue sarcoma patients (2025 · Therapeutic Advances in Medical Oncology · 被引 1)
• Impact of second-opinion pathology review process on diagnostic accuracy in sarcoma: Experience from the NTUH Center of Excellence for Sarcoma. (2026 · Journal of Clinical Oncology)